pharminent

• News

Lilly Medicare GLP-1 Bridge Launches July 1 With Foundayo and Zepbound

pharminent June 26, 2026

• News

Moderna Maps R&D ‘Horizons’ as 2028 Break-Even Goal Looms

pharminent June 26, 2026

• Regulatory

Replimune gets early August decision date for twice-rejected melanoma drug

pharminent June 26, 2026

• Pipeline

Moderna looks out to R&D ‘horizons’ as 2028 break-even goal looms

pharminent June 26, 2026

• M&A / Deals

Immunai and Boehringer partner to identify T-cell targets

pharminent June 26, 2026

• M&A / Deals

Ionis grants Recordati rights to zilganersen for Alexander disease

pharminent June 26, 2026

• News

Merck KGaA to Acquire Bio-Techne for $11.3 Billion in Decade-Defining Life Sciences Bet

pharminent June 25, 2026

• M&A / Deals

Merck buys life sciences firm Bio-Techne in $11.3bn deal

pharminent June 25, 2026

• News

Regeneron’s Cemdisiran Earns FDA Priority Review for gMG

pharminent June 25, 2026

• Regulatory

Ionis secures market expansion for Tryngolza as FDA clears severe hypertriglyceridemia use

pharminent June 25, 2026

• Regulatory

MSD’s Keytruda-Padcev combo secures EC approval for MIBC

pharminent June 25, 2026

• Commercial

Lilly launches its LillyDirect sales channel in the UK

pharminent June 25, 2026

• Manufacturing

SK pharmteco Launches SKyvec Viral Vector Platform for Gene Therapy

pharminent June 24, 2026

• News

Novartis Strikes Up-to-$1.9 Billion Oncology Discovery Collaboration With Antares Therapeutics

pharminent June 24, 2026

• Pipeline

Lundbeck to present new Vyepti and bocunebart data at EAN 2026

pharminent June 24, 2026

• M&A / Deals

URA and Lilly join forces to harmonise drug-wearable obesity care

pharminent June 24, 2026

• M&A / Deals

Boehringer and Combotope partner for cancer antibodies

pharminent June 24, 2026

• Policy / Pricing

EFPIA report adds to pressures on EU drug pricing policy

pharminent June 24, 2026

• News

CARsgen’s Satri-cel Wins World-First CAR-T Approval for Solid Tumor

pharminent June 23, 2026

• Clinical Data

Pfizer drug acquired in Seagen deal disappoints in lung cancer study

pharminent June 23, 2026

• News

Lilly and Astellas Circle Sangamo Assets as the Biotech Files for Bankruptcy

pharminent June 23, 2026

• News

pharminent June 22, 2026

• News

AbbVie to Acquire Apogee Therapeutics for Nearly $11 Billion in Immunology Bet

pharminent June 22, 2026

• M&A / Deals

AbbVie climbs post-Allergan M&A peak with Apogee buy

pharminent June 22, 2026

• M&A / Deals

Lilly bets up to $800M for BioArctic’s brain delivery tech

pharminent June 22, 2026

• Clinical Data

Boehringer advances duo for aggressive cancers into phase 3

pharminent June 22, 2026

• M&A / Deals

Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance

pharminent June 22, 2026

• Commercial

Post-marketing oncology studies: Enabling faster recruitment and lower costs

pharminent June 22, 2026

• M&A / Deals

Sun Pharma to acquire Innovcare Lifesciences for $28.7m

pharminent June 22, 2026

• Commercial

The first 14 days: How specialty programs set patients up for success

pharminent June 22, 2026

• Regulatory

Japan approves Sanofi’s Sarclisa combo for MM treatment

pharminent June 22, 2026

• News

pharminent June 19, 2026

• News

pharminent June 19, 2026

• Commercial

Denali sells FDA voucher for $195M to support neurodegenerative pipeline

pharminent June 19, 2026

• Policy / Pricing

US launches probe of German ‘underpayment’ for medicines

pharminent June 19, 2026

• M&A / Deals

Biogen to acquire RayThera for up to $1bn

pharminent June 19, 2026

• Regulatory

FDA experts endorse Moderna’s mRNA seasonal flu shot

pharminent June 19, 2026

• Policy / Pricing

FDA’s new voucher program hints at broader policy agenda, making many ‘uncomfortable’

pharminent June 19, 2026

• News

pharminent June 18, 2026

• Regulatory

Moderna flu vaccine wins unanimous support from FDA panel

pharminent June 18, 2026